Abstract
Objectives This study aimed to implement an artificial intelligence-assisted psychiatric triage program, assessing its impact on efficiency and resource optimization.
Methods This quality improvement initiative recruited patients on the waitlist for psychiatric evaluation at an outpatient hospital. Participants (n=101) completed a digital triage module that used natural language processing and machine learning to recommend a care intensity level and a disorder-specific digital psychotherapy program. A psychiatrist also assessed the same information and the decisions for care intensity and psychotherapy programs were compared with the artificial intelligence recommendations.
Results The overall wait time to receive care decreased by 71.43% due to this initiative. Additionally, participants received psychological care within three weeks after completing the triage module. In 71.29% of the cases, the artificial intelligence-assisted triage program and the psychiatrist suggested the same treatment intensity and psychotherapy program. Additionally, 63.29% of participants allocated to lower-intensity treatment plans by the AI-assisted triage program did not require psychiatric consultation later.
Conclusions Using artificial intelligence to expedite psychiatric triaging is a promising solution to address long wait times for mental health care. With future accuracy refinements, this could be a valuable tool to implement in hospital settings to assist care teams and improve mental health care. This could result in increased care capacity and improved workflow and decision-making.
Competing Interest Statement
NA and MO co-founded OPTT Inc. and have ownership stakes. The remaining authors declare that the research was conducted without commercial or financial relationships that could be construed as a potential conflict of interest.
Funding Statement
This research was funded by the Ontario Centre of Innovations Innovative Digital Health Solutions Program.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This project received approval from the Queens University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board File 6041568.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Access
Data is available as needed upon request.
